학술논문

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Document Type
Article
Author
Ahmad, NafeesAhuja, Shama DAkkerman, Onno WAlffenaar, Jan-Willem CAnderson, Laura FBaghaei, ParvanehBang, DidiBarry, Pennan MBastos, Mayara LBehera, DigamberBenedetti, AndreaBisson, Gregory PBoeree, Martin JBonnet, MarylineBrode, Sarah KBrust, James C MCai, YingCaumes, EricCegielski, J PeterCentis, RosellaChan, Pei-ChunChan, Edward DChang, Kwok-ChiuCharles, MacarthurCirule, AndraDalcolmo, Margareth PrettiD'Ambrosio, Liade Vries, GerardDheda, KeertanEsmail, AliasgarFlood, JenniferFox, Gregory JFréchet-Jachym, MathildeFregona, GeisaGayoso, ReginaGegia, MedeaGler, Maria TarcelaGu, SueGuglielmetti, LorenzoHoltz, Timothy HHughes, JenniferIsaakidis, PetrosJarlsberg, LeahKempker, Russell RKeshavjee, SalmaanKhan, Faiz AhmadKipiani, MaiaKoenig, Serena PKoh, Won-JungKritski, AfranioKuksa, LigaKvasnovsky, Charlotte LKwak, NakwonLan, ZhiyiLange, ChristophLaniado-Laborín, RafaelLee, MyungsunLeimane, VairaLeung, Chi-ChiuLeung, Eric Chung-ChingLi, Pei ZhiLowenthal, PhilMaciel, Ethel LMarks, Suzanne MMase, SundariMbuagbaw, LawrenceMigliori, Giovanni BMilanov, VladimirMiller, Ann CMitnick, Carole DModongo, ChawangwaMohr, ErikaMonedero, IgnacioNahid, PayamNdjeka, NorbertO'Donnell, Max RPadayatchi, NesriPalmero, DomingoPape, Jean WilliamPodewils, Laura JReynolds, IanRiekstina, VijaRobert, JérômeRodriguez, MariaSeaworth, BarbaraSeung, Kwonjune JSchnippel, KathrynShim, Tae SunSingla, RupakSmith, Sarah ESotgiu, GiovanniSukhbaatar, GanzayaTabarsi, PayamTiberi, SimonTrajman, AneteTrieu, LisaUdwadia, Zarir Fvan der Werf, Tjip SVeziris, NicolasViiklepp, PiretVilbrun, Stalz CharlesWalsh, KathleenWestenhouse, JaniceYew, Wing-WaiYim, Jae-JoonZetola, Nicola MZignol, MatteoMenzies, Dick
Source
The Lancet; September 2018, Vol. 392 Issue: 10150 p821-834, 14p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis.